CBCRP Members 2013-2014:
- Maria Caprio
- Cynthia A. Gomez
- Marjorie C. Green
- Jon Greif
- Karuna Jaggar
- K. Alice Leung
- Melanie Marty
- Janice Mathurin
- Arash Naeim
- Marta Nichols
- Sharima Rasanayagam
- Ted Schettler
- Naz Sykes
- Kristiina Vuori
- David K. Wellisch
Maria Caprio is the Director of the Shanti Project’s Breast Cancer Program based in San Francisco. Since 2008, she’s led a multi-lingual staff in providing free breast cancer Care Navigation and health education to over 500 low-income women annually. Prior to joining staff, Maria was a long-time Shanti Volunteer Advocate providing weekly advocacy and emotional support to undocumented women with breast cancer. Maria began her career as an investment bank analyst with Bank of America Securities in New York and then with Credit Suisse First Boston in London working on a variety of public and private equity finance initiatives. From 2005 to 2008, Maria was an Associate at FTV Capital, a private equity firm in San Francisco, where she spearheaded business development and project management for the firm's successful $512 million fund raising initiative. Maria has a B.A. from Scripps College in International Relations. (9/1/13-8/31/16)Top
Cynthia A. Gómez, PhD, is the founding director of the Health Equity Institute at San Francisco State University. She previously served as co-director of the Center for AIDS Prevention Studies (CAPS) at the University of California at San Francisco and has been a leading scientist in HIV prevention research since1991. Her work has focused primarily on gender, culture and sexual health, on the development of prevention interventions, and on the translation of science to community practice.
Gómez earned a master's degree in Counseling and Consulting Psychology from Harvard University and a PhD in Clinical Psychology from Boston University. Prior to her work in HIV, Gómez spent 12 years working in community health settings, including five as director of a child and family mental health center in Boston.
Gómez has been a health policy advisor for nearly 20 years. She was an appointed member to the Presidential Advisory Council on HIV/AIDS under both WJ Clinton and GW Bush administrations. In 2007 she was appointed by California Governor Arnold Schwarzenegger to the first California Public Health Advisory Council. Over the years she has served on several national advisory committees including the Centers for Disease Control's HIV and STD Advisory Council; Substance Abuse and Mental Health Services Administration's Advisory Committee on Women's Services; and the Institute of Medicine's Committees on Prisoners and Research, and on Lesbian Health. She is a member and past chair of the board of directors of the Guttmacher Institute and serves on several other boards of directors including Public Responsibility in Medicine & Research, Planned Parenthood Shasta Pacific, and the San Francisco Public Health Foundation. (9/1/11–8/31/14)Top
Marjorie C. Green, MD is a Medical Director working in Oncology Product Development for Genentech, Inc. She previously was an Associate Professor of Medicine in the Department of Breast Medical Oncology and the Medical Director of the Nellie B Connally Breast Center at the University of Texas MD Anderson Cancer Center in Houston, Texas. During her tenure at MD Anderson (2001-2012), she also served as a Vice-Chairperson on MD Anderson's Institutional Review Board for more than 7 years. Dr. Green is an experienced clinical researcher, serving as PI for Phase I-III trials including several studies evaluating neoadjuvant therapy for breast cancer and has numerous publications in this field. She received her bachelor's in history from the University of Notre Dame in South Bend, Indiana and her medical degree from the University of Texas Medical Branch in Galveston, Texas. After completing her residency in internal medicine at the University of Virginia, she completed fellowships in medical oncology and hematology at MD Anderson Cancer Center. Currently, Dr. Green is working on the development of trastuzumab emtansine as treatment for patients with breast cancer. (9/1/13-8/31/16)Top
Dr. Jon Greif is a partner in Bay Area Breast Surgeons, Inc., a practice of surgery limited to breast cancer and other diseases of the breast. He is attending breast cancer surgeon at the Carol Ann Read Breast Health Center, the Alta Bates Summit Medical Centers of Oakland and Berkeley, California, and the Valley Care Medical Center in Pleasanton, CA. Prior to moving to the Bay Area in 2006, Dr. Greif was, for 21 years, attending surgeon at Kaiser Permanente Medical Center in San Diego, California, where he chaired the Cancer Committee and Breast and General Tumor Boards. He was faculty at the University of California, San Diego, for 25 years, rising to the rank of Associate Clinical Professor, and currently holds the same rank at Touro University College of Osteopathic Medicine. Dr. Greif is a past president and honorary life member of the Board of Directors of the California Division of the American Cancer Society, and a past member of the National Assembly of the American Cancer Society. He was a perennial "Top Doctor" in San Diego Magazine, and has been named a "Top Doctor" by Oakland Magazine for the past 2 years. (2/7/12-8/31/15)Top
Karuna Jaggar is the Executive Director of Breast Cancer Action, a trusted voice for women's health and the national watchdog of the breast cancer movement. Through independent education and advocacy, BCAction works to address the needs of women living with breast cancer and to stop cancer before it starts. Karuna brings a professional expertise in applied research and policy advocacy to her understanding of the breast cancer epidemic. Before joining BCAction, Karuna's work has focused on women's rights and on eliminating socio-economic inequities. Karuna began her career working with women's microenterprises internationally and in the US, providing self-employment and business training, funding and support for low income women. Karuna was the first East Bay Executive Director for Women's Initiative for Self Employment, where she worked to reverse economic inequities among low-income women and women of color. Karuna holds a Master's degree in Economic Geography from UC Berkeley, with a special emphasis on Women, Gender, and Sexuality, and received her BA from Smith College. Karuna is an alumna of the Women's Policy Institute, a program of the Women's Foundation of California. (9/1/12-8/31/15)Top
K. Alice Leung is the Founder and Principal of Sapientiae, a biotech management consulting firm based in the Bay Area. Sapientiae advises public and private biotech companies in corporate strategy, clinical and commercial development;, as well as provide expert advice and support for public and private investors. Prior to founding Sapientiae, Ms. Leung was the President and Chief Executive Officer of Intarcia Therapeutics, Inc., a biopharmaceutical company in Hayward, CA.
Prior to Intarcia Therapeutics, Inc., Ms. Leung was the Vice President, General Manager of Oncology with Berlex (the US subsidiary of Schering AG, now Bayer), where she was a member of the Executive Committee and oversaw ongoing operations and future development of the oncology business, among other responsibilities. She joined Berlex after a long tenure with Bristol-Myers Squibb (BMS), culminating in the role of Vice President, Worldwide Licensing and External Development and executive committee member in the Pharmaceutical Research Institute of the company.
Currently, Ms. Leung serves on the board for the Gastric Cancer Foundation. She is also the Co-Chair, Membership Committee for the San Francisco chapter of Women in Biotech, as well as a member of the Life Sciences Screening Committee for Springboard Enterprises. Ms. Leung graduated from the University of Western Ontario, in London, Canada, and holds an MBA from the Johnson School of Management at Cornell University. (9/1/13 – 8/31/16)Top
Melanie Marty, Ph.D., is Assistant Deputy Director for Scientific Affairs, Office of Environmental Health Hazard Assessment, California Environmental Protection Agency. Dr. Marty received her Ph.D. from the University of California, Davis in Pharmacology and Toxicology. As Assistant Deputy Director, she oversees production of scientific assessments of environmental chemicals at Cal/EPA, and participates in policy development and administration of the Office. OEHHA is responsible for assessing risk of adverse health outcomes from environmental pollution. These assessments feed into regulatory programs for cleaner air and drinking water, and safer consumer products. Dr. Marty has authored/ co-authored numerous articles and publications relating to environmental risk assessment, including evaluation of children's health risks. She has served on a number of EPA peer review committees and was Chair of the U.S.EPA's Children's Health Protection Advisory Committee from 2001-2009. Dr. Marty is also an Adjunct Assistant Professor at the University of California, Davis, Department of Environmental Toxicology. (9/1/12-8/31/15)Top
Janice Mathurin, MA has more than 15 years of combined professional experience, relevant education and diverse skill set from the nonprofit and for-profit sectors. She currently serves as Director of Operations for West Fresno Family Resource Center, a community-based nonprofit organization dedicated to empowering and supporting the West Fresno community to achieve optimal health and well-being. She manages the implementation and evaluation of culturally and linguistically effective programs/interventions aimed at health improvement, illness prevention, and family strengthening in the vulnerable, low-income, underserved community of Southwest Fresno; responsible for the day-to-day operations of projects for ensuring 100% compliance; fiscal oversight; and policy research. She also serves as a preceptor, providing supervision and opportunities for undergrad and graduate student interns to observe, participate with and learn from practitioners; She is also the former Director of the Fresno Regional Foundation's, Nonprofit Advancement Center (NAC), a capacity building, nonprofit management support center. (9/1/13-8/31/16)Top
Arash Naeim, M.D., Ph.D., is a health professional whose career has spanned a combination of health services, informatics and policy and care issues. He currently serves as Associate Professor of Medicine in the divisions of Hematology-Oncology and Geriatric Medicine at the David Geffen UCLA School of Medicine. He is also director of the Geriatric-Oncology Research and Training Program and Hematology-Oncology Fellowship Program at UCLA, as well as a faculty Assistant Vice Chancellor of Research for Research Informatics. Naeim earned his B.S. in Biochemistry and M.D. in Medicine at the University of California, and received a Ph.D. in Public Policy from the RAND Corporation. His primary research focus is on breast cancer, and other research interests include outcomes research, cost-effectiveness analysis, modeling of health and frailty, and clinical trial design. In 2009, Naeim was selected as the UCLA Principal Investigator for the Athena Breast Health Network. In this capacity he successfully assembled a team of faculty and staff that have planned and started to implement an innovative quality improvement and registry project that serves as the foundation and infrastructure support for the current grant application. Naeim has received numerous honors for his research, including an American Society of Clinical Oncology (ASCO) Young Investigator Award, an NIH Mentored Research Award, California Breast Cancer Research Foundation Award, and UC MRPI Award. He currently serves as a Board Member of the International Society of Geriatric Oncology and the Chair of the Aging and Cancer subcommittee of the American Geriatrics Society. (4/16/12-8/31/15)Top
Marta Nichols is a board member of Breast Cancer Connections, a San Francisco Bay Area nonprofit that provides free programs and services for those touched by breast cancer. Since its founding in 1993, Breast Cancer Connections has supported thousands of individuals with comprehensive, personalized services in an atmosphere of warmth and compassion. She most recently served as Vice President of Investor Relations for Yahoo!, a technology leader and widely-recognized consumer brand, managing all facets of investor and corporate communications. Marta represented Yahoo! as spokesperson and liaison to the investment community and financial press, and also partnered with Yahoo!'s senior executives on a range of issues including financial and executive communications, leadership and culture, strategy, financial planning, and operations. Prior to joining Yahoo! in 2005, Marta was a senior equity research analyst, first at Donaldson Lufkin & Jenrette and later at Banc of America Securities. In her research roles she developed, published, and marketed comprehensive research on leading publicly-traded companies in a variety of industries including media, internet, education, and business services, with an emphasis on creative and differentiated investment ideas for money managers. Her work as an equity analyst was highly ranked by a number of organizations, including the Wall Street Journal, Reuters, Institutional Investor, and Greenwich Associates. Marta holds a Bachelor of Science in Mathematics from the University of San Francisco (USF) and also serves on the USF Board of Trustees Investment Committee, which manages the University's endowment. (9/1/12-8/31/15)Top
Sharima Rasanayagam is the Breast Cancer Fund's Director of Science. She works to ensure that the organization continues to be a national leader in science-based environmental health advocacy. She oversees all of the organization's science-related activities, including monitoring and interpreting emerging scientific research, representing the organization in key scientific bodies, developing and managing science-related program and policy initiatives, and providing scientific guidance on the development of new programmatic initiatives.
Before coming to the Breast Cancer Fund, Dr. Rasanayagam was the founding academic coordinator at the U.C. Berkeley Institute for the Environment, where she built the institute from the ground up and fostered discussions on environmental issues at the University. Previously, she served as consul for science and technology at the U.K. Consulate-General in San Francisco, where she built ties between scientists in the U.K. and California, encouraging collaboration on research and business ventures, with a focus on climate change policy and embryonic stem cell research. Dr. Rasanayagam started her U.K. government service as policy analyst advising on issues ranging from energy policy to crime to small businesses, and took part in the official Inquiry into the outbreak of Bovine Spongiform Encephalopathy (Mad Cow Disease) in the British Isles. She holds a Ph.D. in microbiology from the University of Kent at Canterbury, U.K. (9/1/12-8/31/15)Top
Ted Schettler MD, MPH is Science Director of the Science and Environmental Health Network (www.sehn.org). He also serves as science director of the Collaborative on Health and Environment www.healthandenvironment.org. He has long-standing interests in the many ways that the health of individuals, communities, the general public, and ecosystems are interconnected and has addressed the connections among human health and the food, chemical, built, and social environments in numerous publications and presentations. He has served on advisory committees of the US EPA and National Academy of Sciences. In 2007 he served as a member of the California Breast Cancer Research Program Special Research Initiatives Strategy Team. He has a medical degree from Case Western Reserve University, masters in public health from Harvard University, and practiced medicine primarily in New England for many years. (9/1/12-8/31/15)
Naz Sykes a highly respected nonprofit leader and is recognized for her innovative thinking, her passion to shift the cancer research paradigm, and her expertise in formulating initiatives to empower the public to get involved in the research process. She currently serves as the Executive Director of the Dr. Susan Love Research Foundation (DSLRF) and in the past five years has made substantial impact on the growth of the organization. The Mission of the Dr. Susan Love Research Foundation is to eradicate breast cancer and improve the quality of women's health through innovative research, education and advocacy. In her role at DSLRF, Naz spearheaded the Love/Avon Army of Women initiative, with the goal of recruiting one million women nationwide to take part in breast cancer research studies. Thanks to the success of this initiative, she was able to elevate DSLRF as a national organization, which resulted in a volunteer base that exceeds 340,000 members. Naz also spearheaded the Health of Women Study, the first ever online breast cancer cohort initiative studying potential new risk factors for breast cancer and other diseases in partnership with the National Cancer Institute and City of Hope. In addition to overseeing and setting the strategic direction for the major initiatives of DSLRF, she is also responsible for the overall strategic planning, oversight and fundraising of the organization. Naz received her Bachelor of Science degree in biology and psychology, with a minor in chemistry from the University of Denver and has over 13 years of experience in management, development, and strategic planning for nonprofits. In her previous positions, Naz was the Director of Development for the UCLA School of Nursing as well as the Managing Director for the UCLA Brain Tumor Program. (9/1/10 - 8/31/13)Top
Kristiina Vuori, M.D., Ph.D., is President of the Sanford-Burnham Medical Research Institute, Professor, and Pauline & Stanley Foster Presidential Chair. She earned her M.D. and Ph.D. degrees at University of Oulu, Finland. She received postdoctoral training at Sanford-Burnham in 1992-1995. Dr. Vuori was appointed to Sanford-Burnham faculty in 1996. She was appointed Deputy Director of the Institute’s NCI-designated Cancer Center in 2003, and served as Director of the Cancer Center in 2005-2013. Dr. Vuori has been President of the Institute since 2010. She was appointed interim CEO in January, 2013. Dr. Vuori has received numerous research grants and awards from NIH, NCI, DoD, and is an investigator of the Stand Up To Cancer Dream Team. She serves on numerous advisory capacities to NCI and other cancer organizations. She has served on several NIH and DoD study sections, and serves on Board of Directors for American Association for Cancer Research and California Institute for Regenerative Medicine. She also serves on numerous editorial boards, scientific advisory boards, and as a consultant for pharmaceutical companies. Additionally, she is co-founder of three biotechnology companies. Orally bioavailable drugs to combat chemotherapy-induced anemia that have been developed based on Dr. Vuori’s discoveries are currently in phase II trials. (9/1/13 – 8/31/16)Top
David K. Wellisch, Ph.D. has been a faculty member in the department of Psychiatry and biobehavioral Sciences at the David Geffen School of Medicine at UCLA for 38 years. He is currently Professor-in-Residence and Chief Psychologist in the Adult Division. Dr. Wellisch has a career long interest in both clinical work and clinical research in the area of psycho-oncology. He has had numerous research grants in this area and has approximately 125 scientific articles and book chapters in the area of psycho-oncology. In 2012 Dr. Wellisch was awarded the Naomi Fishman Award for Lifetime Clinical Excellence by the International Psycho-oncology Society. This award is given to the foremost clinician in the world as recognized by the International Psycho-Oncology Society. Dr. Wellisch in the past has served on grant review panels for both the American Cancer Society and for the National Cancer Institute. For several years Dr. Wellisch chaired the Committee on Psychosocial Issues for the American Cancer Society. During his tenure, this committee established a separate and defined research budget and set up a grant review process for psycho-social research in the American Cancer Society which persists to the present time. (9/1/13-8/31/16)Top